MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.440
-0.020 (-1.37%)
Jul 10, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $87.55 million as of July 10, 2026. Its market cap has increased by 71.95% in one year.
Market Cap
87.55M
Enterprise Value
53.14M
1-Year Change
71.95%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $87.55M, an increase of 71.33%. That is a compound annual growth rate of 14.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 87.55M | 49.54% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 91.74M |
| Rein Therapeutics | 91.18M |
| Cardiff Oncology | 90.93M |
| LeonaBio | 90.18M |
| OKYO Pharma | 88.69M |
| NeurAxis | 88.42M |
| Atara Biotherapeutics | 87.94M |
| Rani Therapeutics Holdings | 85.13M |